Romanian Translations
Citations 1-15 of 15 total displayed.
Bevacizumab Beyond Progression: Does This Make Sense?
Lee M. Ellis, Daniel G. Haller
JCO Nov 2008: 5313-5315.
Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)
Axel Grothey, Mary M. Sugrue, David M. Purdie, Wei Dong, Daniel Sargent, Eric Hedrick, Mark Kozloff
JCO Nov 2008: 5326-5334.
Evolution of the Randomized Controlled Trial in Oncology Over Three Decades
Christopher M. Booth, David W. Cescon, Lisa Wang, Ian F. Tannock, Monika K. Krzyzanowska
JCO Nov 2008: 5458-5464.
Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment
Lawrence Fong, Eric J. Small
JCO Nov 2008: 5275-5283.
Across Generations: Cancer Treatment in Developing Countries
Zeba Aziz
JCO Oct 2008: 4990-4991.
Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
Andreas Hermes, Bengt Bergman, Roy Bremnes, Lars Ek, Sverre Fluge, Christer Sederholm, Stein Sundstrøm, Lars Thaning, Jan Vilsvik, Ulf Aasebø, Sverre Sörenson
JCO Sep 2008: 4261-4267.
Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features
Lori J. Goldstein, Robert Gray, Sunil Badve, Barrett H. Childs, Carl Yoshizawa, Steve Rowley, Steven Shak, Frederick L. Baehner, Peter M. Ravdin, Nancy E. Davidson, George W. Sledge, Jr, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Joseph A. Sparano
JCO Sep 2008: 4063-4071.
Stage I Testicular Cancer Management and Necessity for Surgical Expertise
Joel Sheinfeld, Robert J. Motzer
JCO Jun 2008: 2934-2936.
Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group
Peter Albers, Roswitha Siener, Susanne Krege, Hans-Uwe Schmelz, Klaus-Peter Dieckmann, Axel Heidenreich, Peter Kwasny, Maik Pechoel, Jan Lehmann, Sabine Kliesch, Kai-Uwe Köhrmann, Rolf Fimmers, Lothar Weiβbach, Volker Loy, Christian Wittekind, Michael Hartmann
JCO Jun 2008: 2966-2972.
Hepatic Arterial Infusion Chemotherapy for Metatstases From Colorectal Cancer: Is It Really the End of an Era?
Michael D'Angelica, Yuman Fong, Ronald P. DeMatteo, William R. Jarnagin
JCO Jun 2008: 2788-2789.
In Reply
Ryan A. Wilcox, Benjamin Djulbegovic, Gordon H. Guyatt, Victor M. Montori
JCO Jun 2008: 2788.
Basal-Like Breast Cancer: A Critical Review
Emad A. Rakha, Jorge S. Reis-Filho, Ian O. Ellis
JCO May 2008: 2568-2581.
Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
Paul Wheatley-Price, Keyue Ding, Lesley Seymour, Gary M. Clark, Frances A. Shepherd
JCO May 2008: 2350-2357.
Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress
Robert K. Oldham, Robert O. Dillman
JCO Apr 2008: 1774-1777.
Meta-Analysis of Hepatic Arterial Infusion for Unresectable Liver Metastases From Colorectal Cancer: The End of an Era?
Simone Mocellin, Pierluigi Pilati, Mario Lise, Donato Nitti
JCO Dec 2007: 5649-5654.